/Stryker%20Corp_%20HQ%20sign%20-by%20Sundry%20Photography%20via%20Shutterstock.jpg)
Valued at a market cap of $131.5 billion, Stryker Corporation (SYK) is a medical technology company that is widely recognized for its market-leading Mako robotic-arm assisted surgery platform and a diverse portfolio that includes joint replacement implants, surgical equipment, and neurovascular intervention tools. The Portage, Michigan-based company is expected to announce its fiscal Q1 earnings for 2026 after the market closes on Thursday, Apr. 30.
Ahead of this event, analysts expect this healthcare company to report a profit of $2.99 per share, up 5.3% from $2.84 per share in the year-ago quarter. The company has topped Wall Street’s bottom-line estimates in each of the last four quarters. In Q4 2025, SYK’s EPS of $4.47 outpaced the consensus expectations by 1.6%.